Search Articles — Sudonull

Search Results

In this project

Hash tables and cache conflicts: benchmarks

https://sudonull.com/hash-tables-and-cache-conflicts-benchmarks

Analysis of cache misses in hash tables: chaining vs probing, FNV-1a, Robin Hood. Benchmarks show a 3x speedup. Optimize data structures for real performance — read the details.

CSS3 support in browsers: prefixes table

https://sudonull.com/css3-support-in-browsers-prefixes-table

Detailed CSS3 properties compatibility table across browsers: versions, prefixes -webkit-, -moz-, -ms-. Guide for middle/senior developers. Check support and optimize code now.

Flink real-time JOIN: tables 4+2 TB

https://sudonull.com/flink-real-time-join-tables-4-2-tb

Implementation of stateful JOIN on Apache Flink for real-time result updates between terabyte tables. Table API, KeyedCoProcessFunction, MapState. Code and architecture for middle/senior.

Open_slate tablet with physical disconnection of mic and camera

https://sudonull.com/open-slate-tablet-with-physical-disconnection-of-mic-and-camera

Learn about open_slate on MediaTek Genio 720: hardware kill-switches for privacy, modularity, Android/Linux. Specs, prices, scenarios for developers. Suitable for secure dev.

Parallel Chunk Merging Manticore Search

https://sudonull.com/parallel-chunk-merging-manticore-search

Speed up RT-table compaction in Manticore Search 24.4.0: parallel merges up to 6.8x faster. Benchmarks, settings parallel_chunk_merges and merge_chunks_per_job. Configure for RT workloads.

From other projects

Hana Gouda Makes History at Table Tennis World Cup

https://lrivo.com/hana-gouda-makes-history-at-table-tennis-world-cup

Egyptian table tennis star Hana Gouda achieved a historic first by reaching the Women's World Cup quarter-finals. Discover the impact of her groundbreaking success.

Kasımpaşa Climbs Süper Lig Table After Key Win

https://lrivo.com/kasımpas-a-climbs-su-per-lig-table-after-key-win

Kasımpaşa secured a crucial 2-0 victory over Kayserispor, highlighted by a goalkeeper's long-range goal, boosting their league position. Read the full match analysis.

Oral GLP-1 tablet for weight loss: EMA analysis

https://ymaho.com/oral-glp-1-tablet-for-weight-loss-ema-analysis

EMA decision analysis on oral semaglutide (Wegovy Pill). OASIS 4 data, investments in Ireland and competition with Lilly. Read forecasts and hidden risks.

Rio Ave vs Alverca: Liga Portugal Mid-Table Fight

https://lrivo.com/rio-ave-vs-alverca-liga-portugal-mid-table-fight

Catch up on the crucial Liga Portugal match between Rio Ave and Alverca. Learn about their recent form, key players, and what's at stake in this mid-table battle for survival.

2. Bundesliga Draw: Braunschweig & Nürnberg Climb Table

https://lrivo.com/2-bundesliga-draw-braunschweig-nu-rnberg-climb-table

An eventful 2. Bundesliga match saw Eintracht Braunschweig and 1. FC Nürnberg draw 1-1, impacting their league positions. Get the full match breakdown and table changes.

Dresden Beats Bochum: Bobzien Masterclass Shifts Table

https://lrivo.com/dresden-beats-bochum-bobzien-masterclass-shifts-table

Dynamo Dresden secure a crucial win over Bochum thanks to Ben Bobzien's playmaking. See how the result impacts the 2. Bundesliga standings and what's next.

FC Twente Beats Ajax 2-1, Shakes Up Eredivisie Table

https://lrivo.com/fc-twente-beats-ajax-2-1-shakes-up-eredivisie-table

FC Twente secured a crucial 2-1 victory over Ajax at Johan Cruijff ArenA, shaking up the Eredivisie table. Discover the match highlights and what this means for both clubs.

J&J's OTTAVA Robot: Trials and a Shift in the Surgery Market

https://ymaho.com/j-j-s-ottava-robot-trials-and-a-shift-in-the-surgery-market

J&J tested the OTTAVA robot with table-integrated arms for bariatric surgery. The system works in cramped operating rooms, reducing hospital costs. Learn how this will change the market.

Vepdegestrant: FDA approved the first PROTAC degrader

https://ymaho.com/vepdegestrant-fda-approved-the-first-protac-degrader

FDA approved Vepdegestrant — the first protein degrader tablet for ESR1-mutant breast cancer. PFS 5 months vs 2.1 for fulvestrant. Learn why this is a paradigm shift.

Trending Now